Literature DB >> 26682243

The epigenetic regulator CTCF modulates BCL6 in lymphoma.

Ana Batlle-López1, María G Cortiguera1, M Dolores Delgado1.   

Abstract

Entities:  

Keywords:  BCL6; CTCF; epigenetics; lymphoma

Year:  2015        PMID: 26682243      PMCID: PMC4671918          DOI: 10.18632/oncoscience.239

Source DB:  PubMed          Journal:  Oncoscience        ISSN: 2331-4737


× No keyword cloud information.
  5 in total

Review 1.  Cancer epigenetics: from mechanism to therapy.

Authors:  Mark A Dawson; Tony Kouzarides
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

Review 2.  CTCF: master weaver of the genome.

Authors:  Jennifer E Phillips; Victor G Corces
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

3.  DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.

Authors:  Anne Y Lai; Mehrnaz Fatemi; Archana Dhasarathy; Christine Malone; Steve E Sobol; Cissy Geigerman; David L Jaye; Deepak Mav; Ruchir Shah; Leping Li; Paul A Wade
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

4.  Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.

Authors:  A Batlle-López; M G Cortiguera; M Rosa-Garrido; R Blanco; E del Cerro; V Torrano; S D Wagner; M D Delgado
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

Review 5.  Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.

Authors:  Katerina Hatzi; Ari Melnick
Journal:  Trends Mol Med       Date:  2014-03-31       Impact factor: 11.951

  5 in total
  1 in total

1.  Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells.

Authors:  María G Cortiguera; Lorena García-Gaipo; Simon D Wagner; Javier León; Ana Batlle-López; M Dolores Delgado
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.